ElevateBio

Powering the creation of cell & gene therapies at a speed the world deserves.

Elevated Insights

From gene editing to biomanufacturing, learn more about the cell and gene therapy industry from our team of industry-leading experts

Featured Insights

// Feb 2026

From Innovation to Impact: Building on Pittsburgh’s Legacy to Industrialize Advanced Therapies

Katie Shannon, VP, Site Head, BaseCamp Pittsburgh

View Insight

// Feb 2026

10 Questions to Ask When Choosing a Cell Therapy CDMO

Mike Paglia, Chief Technology Officer

View Insight

// Feb 2026

Why FDA Complete Response Letters Involve Manufacturing Issues – and What Must Change in Cell Therapy

By Cindy Riggins, Head of CMC Regulatory Affairs, ElevateBio

View Insight

// Nov 2025

Scaling Cell and Gene Therapies: Crossing the Inflection Point

By Mike Paglia, Chief Technology Officer, ElevateBio

View Insight

// Jun 2024

How ElevateBio’s Foundry Model is Changing the Future of Genetic Medicines

By David Hallal, Chairman and CEO, ElevateBio

View Insight

// Nov 2023

A new chapter in gene editing: The diversity, versatility, and coolness of Life Edit’s technologies

By Hui-Chia Yu-Kemp and Drew Kelso, Technology Development Scientists, Life Edit Therapeutics, an ElevateBio company

View Insight

// Oct 2023

Biotechnology: The Key to America’s Next Manufacturing Revolution

By Heidi Wagner, Global Head of Government Affairs, and Mike Paglia, Chief Operating Officer of ElevateBio BaseCamp

View Insight

// Aug 2023

Partner Case Study: Accelerating Treg Therapy Manufacturing

By ElevateBio and Abata Therapeutics

View Insight

// Jan 2023

Reflecting on ElevateBio’s First Five Years

From our Chairman and CEO, David Hallal

View Insight

// Nov 2022

ElevateBio’s Lentiviral Vector Platform: Right the first time

By: Mercedes Segura, Vice President, Process Development, ElevateBio, Dawn Maier, Vice President, Emerging Technologies, ElevateBio, and Bojiao Yin, Director of Vector Process Development, ElevateBio

View Insight

// Nov 2022

The Medicines of Tomorrow: A primer on the gene editing landscape

By Adrian Oliver, Ph.D., Senior Scientist of Technology Development, Life Edit Therapeutics

View Insight

// Nov 2022

Right from the start: Successfully managing the life cycles of cell and gene therapies

By Mike Paglia, Chief Operating Officer ElevateBio BaseCamp

View Insight

MENU